Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer
Open Access
- 1 April 1994
- journal article
- Published by Wiley in The Laryngoscope
- Vol. 104 (4) , 468-472
- https://doi.org/10.1288/00005537-199404000-00012
Abstract
Tumor cell kinetics were studied in vivo in a series of 97 patients with oropharyngeal cancer. The duration of S phase (tS), the labeling index (LI), and the potential doubling time (Tpot) were obtained by flow cytometry measurements of a tumor biopsy obtained after intravenous injection of 200 mg 5-bromodeoxyuridine to the patient. The mean LI was 9.7% (standard deviation [SD], 5.4), the mean tS was 10.1 hours (SD, 3.6), and the mean Tpot was 4.6 days (SD, 3.5). No significant relationship was found between the Tpot or LI and the size of the tumor, nodal status, histological grade, or the site of the primary within the oropharynx. Conversely, aneuploid tumors had longer tS (P<.001), higher LI (P<.001), and shorter Tpot (P<.05) than the diploid tumors. The mean LI and Tpot of the tumors obtained after induction chemotherapy were significantly higher and shorter, respectively, than those measured before any treatment. The data strongly suggest that rapid tumor cell proliferation frequently occurs in oropharyngeal cancer which had responded poorly to chemotherapy.Keywords
This publication has 16 references indexed in Scilit:
- The phantom of tumor treatment - continually rapid proliferation unmaskedRadiotherapy and Oncology, 1991
- The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim reportInternational Journal of Radiation Oncology*Biology*Physics, 1990
- The rationale for continuous, hyperfractionated, accelerated radiotherapy (chart)International Journal of Radiation Oncology*Biology*Physics, 1990
- Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck regionInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Adjuvant chemotherapy for head and neck cancer.Journal of Clinical Oncology, 1989
- Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer.Journal of Clinical Oncology, 1989
- Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer.Journal of Clinical Oncology, 1989
- Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complicationsInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Human tumour cell kinetics using a monoclonal antibody against iododeoxyuridine: Intratumour sampling variationsRadiotherapy and Oncology, 1988
- Accelerated fractionation vs hyperfractionation: Rationales for several treatments per dayInternational Journal of Radiation Oncology*Biology*Physics, 1983